Endogenous Catecholamines in Immune Cells: Discovery, Functions And Clinical Potential as Therapeutic Targets
Beta-Blockers Emerge as Beneficial in Early and Triple-Negative Breast Cancer: Reasons Why and the Role of a Sympathetic Overdrive in TNBC Patients
Timing is everything: Novel Combinatorial Approaches to Overcome the Immunosuppression in Prostate Cancer
Donna Jackson Nakazawa and Her New Book, THE ANGEL AND THE ASSASSIN: The Tiny Brain Cell that Changed the Course of Medicine
Cognitive Decline and Alzheimer’s Linked to Low Systemic REST Levels and Deficient Stress Protection of the Aging Brain
Beta-adrenoceptor Activation Reduces Host Viral Resistance by Preventing IFN-γ Production in Liver NK CellsFebruary 18, 2021
Neuroendocrine Phenotypes that Affect Immune Responses in Mammals Found in Avian SpeciesOctober 15, 2021
Identification of GM-SCF as possible distinctive blood marker predicting severe COVID-19March 23, 2021
The IL-6 Inhibitors Tocilizumab and Sarilumab and COVID-19 Treatment: Controversies but Potential Efficacy in Severe CasesFebruary 6, 2021
Immunomodulatory and anti-inflammatory neuropeptides: Production by specific gut microbiota genera – in silico evidenceMay 7, 2019
Norepinephrine through beta2-adrenoceptor activation down-regulates pro-inflammatory pathogenic Th17 cells in a rodent model of rheumatoid arthritisMarch 20, 2018
First Evidence that Catecholamines Inhibit IL-27 Production by Antigen Presenting CellsJanuary 6, 2018
